DAILIES TOTAL1® Lens Centration in a Japanese Population

December 24, 2015 updated by: Alcon Research

Pilot Evaluation of DAILIES TOTAL1® Lens Centration in a Japanese Population

The purpose of this study is to compare the lens centration of DAILIES TOTAL1® (DT1) contact lenses to 1-DAY ACUVUE® Tru-Eye® (1DAVTE) contact lenses in a Japanese population after 7 ± 2 days of wearing of each product.

Study Overview

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tokyo, Japan
        • Contact Alcon Japan Ltd. for Trial Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Sign Informed Consent document.
  • Habitually wear soft contact lenses on a daily disposable or weekly/monthly replacement basis.
  • Symptoms of contact lens discomfort as defined by protocol.
  • Require contact lenses within the power range of -0.50 diopter (D) to -10.00 D.
  • Cylinder, if present, less or equal to 0.75D in either eyes at Visit 1.
  • Vision correctable to 20/25 or 0.1 (logMAR) or better in each eye at distance with pre-study lenses at Visit 1.
  • Acceptable contact lens fit with both study contact lenses.
  • Willing to wear lenses every day for at least for a minimum of five days per week six hours per day, every day if possible and attend all study visits.
  • Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

  • Currently wearing DT1 or 1DAVTE.
  • Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear.
  • Use of systemic or ocular medications which contact lens wear could be contraindicated as determined by the investigator.
  • Eye injury or surgery within twelve weeks immediately prior to enrollment for this trial.
  • Any moderate or severe ocular condition observed during the slit-lamp examination at the enrollment visit.
  • History of herpetic keratitis, ocular surgery or irregular cornea.
  • Prior refractive surgery (e.g. LASIK, PRK, etc).
  • Monocular subjects (only one eye with functional vision) or subjects fit with only one lens.
  • Judged ineligible as a patient in this clinical study by the investigator.
  • Other protocol-defined exclusion criteria may apply.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: DT1, then 1DAVTE
Delefilcon A contact lenses worn first, followed by narafilcon A contact lenses. Each product worn bilaterally for 7 days on a daily wear, daily disposable basis.
Silicone hydrogel contact lenses (8.5 and 8.8 base curves) dispensed per manufacturer's guidelines for daily disposable wear
Other Names:
  • DAILIES TOTAL1®
Silicone hydrogel contact lenses (8.5 and 9.0 base curves) dispensed per manufacturer's guidelines for daily disposable wear
Other Names:
  • 1-DAY ACUVUE® TruEye®
Other: 1DAVTE, then DT1
Narafilcon A contact lenses worn first, followed by delefilcon A contact lenses. Each product worn bilaterally for 7 days on a daily wear, daily disposable basis.
Silicone hydrogel contact lenses (8.5 and 8.8 base curves) dispensed per manufacturer's guidelines for daily disposable wear
Other Names:
  • DAILIES TOTAL1®
Silicone hydrogel contact lenses (8.5 and 9.0 base curves) dispensed per manufacturer's guidelines for daily disposable wear
Other Names:
  • 1-DAY ACUVUE® TruEye®

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success Rate of Lens Centration After 7 ± 2 Days of Wear
Time Frame: Day 7, each product
Lens centration (the centration of the contact lens over the cornea) was rated by the investigator during slit lamp examination using a 5-point scale (0=optimal, 4=severe decentration). Success was defined as the percentage of subjects whose lens centration was rated as "optimal" or "slight decentration. One eye (study eye) was analyzed.
Day 7, each product

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Senior Manager, Clinical Development, Alcon Japan, Ltd.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

September 26, 2014

First Submitted That Met QC Criteria

September 29, 2014

First Posted (Estimate)

September 30, 2014

Study Record Updates

Last Update Posted (Estimate)

January 29, 2016

Last Update Submitted That Met QC Criteria

December 24, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ALJ-V2014-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractive Error

Clinical Trials on Delefilcon A contact lenses

Subscribe